Oxacillin Injection, Powder, For Solution
Product Images NDC 63323-811

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oxacillin (NDC 63323-811). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Oxa0o 0000 01)

FDA Label Image

Logo (Oxa0o 0000 02)

FDA Label Image

Vialpbp (Oxa0o 0000 03)

Vialpbp (Oxa0o 0000 03)
This is a product label for a Pharmacy Bulk Package of Oxacillin, a sterile and non-pyrogenic drug used for intravenous admixtures. Each bottle contains Oxacillin monohydrate equivalent to 10 grams and 21 mg of disodium phosphate per gram of full exchange gram. The recommended dosage information is indicated in the package insert. The contents should be used within four hours after the initial closure puncture and dispensed via a suitable dispensing set under a laminar flow hood using aseptic technique. This drug is not intended for direct infusion, and the container closure is not made with natural rubber latex. The storage temperature is between 20°C to 25°C (68°F to 77°F).*
FDA Label Image

Pbpctn (Oxa0o 0000 04)

Pbpctn (Oxa0o 0000 04)
The text appears to be a set of instructions for the reconstitution of Oxacillin for Injection, a USP product. The instructions include adding sterile water for injection or sodium chloride injection, obtaining a resulting solution of 100 mg oxacillin active per mL. The container closure is not made with natural rubber latex. The sterile powder should be stored at 20 to 25°C, and withdrawal of the contents should be completed without delay. If prompt fluid transfer cannot be accomplished, discard the contents no later than 4 hours after initial closure puncture. The pharmacy bulk package is not for direct infusion, and it is intended for preparing intravenous admixtures only. The text also provides dosage information for usual adult usage. The manufacturer is Fresenius Kabi, Lake Zurich, and the product is made in Italy.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.